Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.

    • About

      About - ADNI | Alzheimer's Disease Neuroimaging Initiative

    • News & Publications

      News & Publications - ADNI | Alzheimer's Disease...

    • HELP / FAQ

      HELP / FAQ - ADNI | Alzheimer's Disease Neuroimaging...

  2. Data, including clinical, biofluid, genetic, imaging, and neuropathology results from ADNI participants, are shared with approved researchers through the LONI Image and Data Archive (IDA), a secure research data repository. Samples, including genetic material, blood, and brain tissue collected from ADNI participants, are available for analyses ...

  3. 28 Σεπ 2021 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) has accumulated 15 years of clinical, neuroimaging, cognitive, biofluid biomarker and genetic data, and biofluid samples available to researchers, resulting in more than 3500 publications. This review covers studies from 2018 to 2020.

  4. 19 Σεπ 2008 · The overall goals of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Clinical Protocol will be to recruit 800 subjects and carry out all clinical evaluations including: neuropsychological and clinical assessments, imaging studies and collection of biomarkers. To carry out this protocol we will: A.1. SUPPORTIVE 1.

  5. 26 Φεβ 2008 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) study is a longitudinal multisite observational study of elderly individuals with normal cognition, mild cognitive impairment (MCI), or AD (11, 12). It is jointly funded by the National Institutes of Health (NIH) and industry via the Foundation for the NIH.

  6. 12 Σεπ 2023 · ADNI is an observational study designed like a longitudinal clinical trial, and since its founding in 2004 1 has enrolled and followed 868 cognitively unimpaired (CU) participants, 1090 with mild cognitive impairment (MCI), and 408 with dementia diagnosed as AD.

  7. 13 Αυγ 2024 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a public-private partnership aimed at studying cognitive aging, MCI, and early Alzheimer's to evaluate biomarkers.

  1. Γίνεται επίσης αναζήτηση για